Levetiracetam (Keppra) Loading Dose for Adults
For benzodiazepine-refractory status epilepticus in adults, administer levetiracetam 60 mg/kg IV (maximum 4,500 mg) as a 15-minute infusion. 1, 2
Standard Loading Dose Regimen
Status Epilepticus (Second-Line After Benzodiazepines)
- Dose: 60 mg/kg IV (maximum 4,500 mg single dose) 1, 2
- Route: Intravenous infusion over 15 minutes 3
- Dilution: Dilute in 100 mL compatible diluent (0.9% NaCl, lactated Ringer's, or D5W); maximum concentration 15 mg/mL 3
- Efficacy: Terminates seizures in approximately 47% of patients, comparable to fosphenytoin and valproate 4, 2
Alternative Dosing Considerations
- 40 mg/kg (maximum 2,500 mg) is an acceptable alternative supported by pediatric and some adult guidelines 1, 2
- Recent evidence suggests ≥30 mg/kg provides superior seizure termination compared to lower doses (66% vs 40% success rate) 5
- Doses **<30 mg/kg** may fail to achieve sustained therapeutic concentrations (>12 mg/L at 12 hours) in patients >60 kg 6
Administration Methods
IV Push vs. Infusion
- IV push administration reduces time to drug delivery (12 vs 38 minutes) without increasing adverse events 7
- High-dose (≥3,000 mg) IV push is relatively well-tolerated but requires hemodynamic monitoring 8
- Standard FDA-labeled administration remains 15-minute infusion 3
Non-Status Epilepticus Indications
Routine Seizure Management (Not Status Epilepticus)
The FDA label does not specify loading doses for non-emergent situations. Standard initiation: 3
- Adults: 500 mg IV twice daily, increase by 500 mg twice daily every 2 weeks to target 1,500 mg twice daily
- Pediatric (4-16 years): 10 mg/kg twice daily, increase by 10 mg/kg every 2 weeks to 30 mg/kg twice daily
Safety Profile
Adverse Events
- Hypotension: 0.7% with levetiracetam vs 3.2% with fosphenytoin 4, 2
- Respiratory depression: Lower incidence than traditional agents 2
- Intubation rates: Higher with doses ≥40 mg/kg (45.8%) compared to lower doses (26.8-28.2%), though causality unclear 9
- High-dose IV push (≥3,000 mg) associated with 9.2% hypotension rate, often confounded by concurrent medications 8
Critical Monitoring
- Monitor blood pressure and heart rate during and after infusion 8
- No routine therapeutic drug level monitoring required 10
- Periodic CBC monitoring recommended 10
Renal Dose Adjustments
For patients with renal impairment, adjust maintenance dosing (not loading dose): 3
- CrCl >80: 500-1,500 mg every 12 hours
- CrCl 50-80: 500-1,000 mg every 12 hours
- CrCl 30-50: 250-750 mg every 12 hours
- CrCl <30: 250-500 mg every 12 hours
- ESRD on dialysis: 500-1,000 mg every 24 hours (plus 250-500 mg post-dialysis)
Common Pitfalls
- Underdosing: Fixed doses <3,000 mg or weight-based doses <30 mg/kg may not achieve therapeutic levels before maintenance dosing begins 6
- Abrupt discontinuation: Taper gradually to avoid withdrawal seizures and status epilepticus 3
- Ignoring renal function: Failure to adjust maintenance doses in renal impairment leads to accumulation 3
- Delayed administration: Prolonged infusion preparation delays seizure control; consider IV push in emergencies 7